Roque: PH to purchase 4 COVID-19 vaccine brands

enablePagination: false
maxItemsPerPage: 10
maxPaginationLinks: 10


Metro Manila (CNN Philippines, December 1) — Presidential spokesperson Harry Roque on Tuesday named four COVID-19 vaccine brands from China, Russia, United States, and the United Kingdom that the Philippine government will procure.

Citing information from vaccine czar Carlito Galvez Jr., he said the Philippines will purchase vaccines from China's Sinovac, Pfizer from US, UK's AstraZeneca, and Sputnik V from Russia's Gamaleya.

"Apat na po ang sinabi ni Secretary Galvez na gagamitin natin: Ang Sinovac, AstraZeneca, Pfizer, at Gamaleya," he said in a media briefing.

[Translation: Secretary Galvez said we will use Sinovac, AstraZeneca, Pfizer, and Gamaleya.]

Dr. Lulu Bravo, executive director of the Philippine Foundation for Vaccination, cited the positive findings of AstraZeneca and Pfizer. But she noted that Sinovac and Sputnik V have yet to release data from the last stage of their clinical trials.

"Ang Phase 3 hindi pa nila pinapakita. Hindi madaling desisyunan kung hindi mo nakikita ang full scientific data," she said in the same briefing.

[Translation: They have not yet shown the findings of their Phase 3 trial. It's not easy to decide if you haven't seen the full scientific data.]

AstraZeneca Oxford vaccine is 70% effective on average, while Pfizer and BioNTech said their vaccine is 95% effective, based on their company press releases.

The Philippines has secured 2.6 million doses of AstraZeneca vaccines through a tripartite agreement with the private sector, with plans for additional purchase from the government. Sinovac and Gamaleya have applied to hold Phase 3 clinical trials in the country to see its safety and efficacy on a large group of Filipinos.

The country's COVID-19 task force is looking to administer vaccines to at least 60 million Filipinos to achieve herd immunity, where virus transmissions will be limited. ​Galvez earlier said a number of provinces will receive different types of vaccine, which will be chosen with logistics in mind.

The vaccination program will last for three to five years for the more than 100 million Filipinos.